Objective: To examine the correlation between synovial fluid cartilage markers and degree of cartilage damage determined by arthroscopic evaluation in subjects with acute knee injury.
Introduction
IN the U.S., osteoarthritis (OA) is second only to ischemic heart disease as a cause of work disability in men over 50 years of age, accounting for more hospitalizations than rheumatoid arthritis each year [1] . Despite this public health impact, current available OA therapies are generally palliative and delivered late in the disease course, when destruction of articular cartilage is advanced and detectable radiographically [2] . Based on studies of OA in animal models, it is suspected that the peak of disease activity occurs well before the condition can be diagnosed radiographically [3] . Thus, the identification of sensitive markers for the earlier stages of osteoarthritis (preradiographic OA), and an understanding of the correlation of markers to disease course and severity, would represent a major advance, facilitating early diagnosis, treatment monitoring and the rational development of effective therapy.
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Epitopes of cartilage extracellular matrix molecules found in body fluids are potential indicators of the state of cartilage metabolism and arthritis. A subpopulation of patients with acute injury of the knee provides a model system for evaluating whether the distribution and concentration of these markers correlates with the extent of articular cartilage damage at an early stage, prior to radiographic evidence of joint disease [3] . 3B3(-) is a neo-epitope on chondroitin-6-sulfate (CS) chains detected by monoclonal antibody (MAb) 3B3 in the absence of chondroitinase ABC pretreatment. 3B3(-) expression is low or absent in normal cartilage specimens and demonstrable in arthritis where cartilage degeneration, remodeling and repair are greatest [4] . 3B3(-) has been detected in synovial fluid (SF) from OA and chronically injured joints (>4 weeks duration) but not from acutely injured joints (<4 weeks duration) [5] . 3B3(+), is a chondroitinasegenerated CS epitope identified by MAb 3B3 representative of unsaturated CS in proteoglycan [4] . Chondroitinase-generated CS has been shown to be lower in SF from OA and rheumatoid arthritic joints compared with normals [6] . The MAb 5D4 reacts against several repeats of a highly sulfated heptasaccharide in keratan sulfate (KS), a glycosaminoglycan (GAG) found in cartilage proteoglycan [7] . Lower SF concentrations of KS are found in acutely injured human knees compared with the contralateral uninjured knees of the same patients [8] , in arthritic human joints compared with normal controls [6] , and in OA compared with chronically injured joints [5] .
Hyaluronic acid (HA) can originate from both synovium and cartilage but is generally considered a marker of synovial inflammation [9] . The concentration of HA in SF has been shown to be lower in acutely injured effusive joints compared with acutely injured non-effusive or normal joints [10] . To date SF levels of HA have not been compared with arthroscopic evidence of chondral damage.
The purpose of this study was to examine the diagnostic value of SF marker levels in effusive acutely injured knee joints by comparing marker levels to chondral lesion severity as determined by a validated arthroscopic scoring system. SF marker levels from joints with chondral damage were compared with levels from joints without chondral damage in subjects with acute knee injury duration of less than 4 months. Advantages of the acute knee injury model system include knowledge of the event inciting cartilage damage, precise diagnosis of the injury through arthroscopy, and a comparatively rapid disease process [3] .
Patients and Methods

DESIGN
We performed a prospective study of acute knee injury, defined as an interval from injury of less than 4 months, presenting for orthopaedic evaluation and deemed to require arthroscopy. The design was a blinded comparison of chondral damage (quantitated arthroscopically using a validated scoring system) and SF concentrations of the cartilage extracellular matrix constituents, 3B3(-) neo-epitope, 3B3(+) chondroitinase-generated CS epitope of proteoglycan, KS, and HA using enzyme-linked immunosorbent assays (ELISA) and total GAG.
PATIENTS
Patients meeting the following criteria were recruited consecutively from the Sports Medicine Clinic at Duke University Medical Center: (1) scheduled to undergo non-research arthroscopy, (2) acute knee injury within 4 months of arthroscopy, (3) patient age between 18 and 60 years, (4) no evidence of joint pathology on plain radiographs, (5) no history of intra-articular or oral corticosteroid exposure, (6) no other rheumatologic disorder. The majority of patients were referred from either the local health maintenance organization (the Duke Health Network), the Duke University Student Health Service, or fee for service. The study thus included a broad range of knee injuries and age groups. Knee radiographs included standing anteroposterior and lateral views reviewed by a single observer (A.E.B.) who was blinded to biochemical and arthroscopic data. The choice of patients with duration of injury less than 4 months was based upon evidence from previous studies showing alteration in the concentrations of SF cartilage matrix components by knee injury during this time interval [3] . A clinical description of the 20 patients with acute knee injury is summarized in Table I . The age range of patients was from 19-57 years, with a median of 34 years, and all patients had normal knee radiographs, although two had histories of knee trauma without effusion more than 1 year before study entry. The majority were male (18/20) , and sustained an acute injury to the knee a mean of 9.3 weeks before arthroscopy. All subjects showed evidence of internal derangement at arthroscopy: nine with both an anterior cruciate ligament (ACL) and a meniscal tear, seven with an ACL tear only, and four with a meniscal tear only. Abnormal synovium was apparent in 13 participants. The study was approved by the institutional review board at Duke University Medical Center. SF SF was aspirated from the suprapatellar pouch before injection of intra-articular anesthesia for arthroscopy. Fluid was immediately aliquoted and stored at -70~ CRITERION STANDARD Arthroscopic examination of the knee was done using the French Society of Arthroscopy (SFA) system for assessing articular cartilage which has been validated [11] [12] [13] . This instrument scores all three compartments of the knee (medial, lateral, and patellofemoral), yielding a continuous variable between 0 and 100 for each compartment. The following formula was used to determine the score:
SFA score=size (%) of grade I lesion x 0.14 + size (%) of grade II lesions x 0.34 + size (%) of grade III lesions x 0.65 + size (%) of grade IV lesions x 1.00.
Lesion size, size (%), is expressed as a percent based on a visual analog scale as scored by the arthroscopist. For each compartment, the size (%) for a particular grade corresponds to the mean value for the two articular surfaces of the compartment [12] . Grade was based on a classification of chondropathy in which 0 indicates normal cartilage, I indicates swelling and softening, II indicates superficial fibrillation, III indicates deep fibrillation, and IV indicates exposure of subchondral bone [13] . Other internal derangements were recorded, such as ACL tear, meniscal injury or the presence of abnormal synovium, defined as hyperemia, thickening or villous proliferation. All evaluations were performed by a single examiner (W.E.G.).
MEASUREMENT OFSULFATED TOTAL GAG SF GAG content was quantitated using the 1,9-dimethylmethylene blue dye (Aldrich 34,108-8) assay performed according to the method of Farndale [14] with modifications [8 15] . Shark CS standards (Sigma C4384) in the range of 0-50 pg/ml were prepared in water, and the shift in the absorbance after the addition of the dye was monitored immediately at 540 nm on an Anthos Reader 2001.
3B3 ELISA
A quantitative ELISA was developed for 3B3(-) neo-epitope recognized by the MAb 3B3. This assay was carried out in 96-well microtiter plates (Immulon 4, Scientific Products), coated overnight at 4~ with a bovine aggrecan core standard protein (chondroitinase ABC-digested A1D1 fraction of bovine nasal cartilage, BNC) in 0.02 M sodium carbonate, pH 9.6, 100 pl/well. Known concentrations of bovine core standard or serially diluted SF samples were prepared in Tris 1B (an incubation buffer containing 0.01 M Tris-HC1 pH 7.4, 0.15 M NaC1, 0.1% Nonidet P-40, 0.1% bovine serum albumin and 0.003 M sodium azide). Sixty microliters of standard or sample were mixed with 60 pl 3B3 MAb (1:30 000 final dilution) and incubated overnight at 4~ Replicate assays of all samples were performed. For 3B3(-) determination, SF was not digested with chondroitinase ABC; for 3B3(+), SF was digested with chondroitinase before assay. Antigen coated plates were washed four times with Tris IB then blocked with 100 ~l of a 1% bovine serum albumin solution in Tris IB for 90min at 37~
The remainder of the assay conformed with previously published methods [15] with the exception that Tris IB was used as the incubation buffer throughout. The absorbance at 405 nm was read on an Anthos Reader 2001. The amount of epitope in the samples was calculated from the absorbance readings falling within the linear portion of the standard curve and expressed in micrograms per milliliter.
5D4 ELISA
Determination of KS levels in SF using the 5D4 MAb was carried out using the 3B3 ELISA protocol except, 5D4 antibody was used at a final dilution of 1 : 250 000. These assays were normalized to an international standard competitor, 'KS-2', kindly provided by Dr Eugene Thonar. A 1.0 ng protein sample of our aggrecan standard was found to be equivalent to 0.12 ng of purified KS-2. All KS results are reported as microgram per milliliter of KS-2 equivalent.
MEASUREMENT OF HA
HA was measured by competitive ELISA using a modification of a procedure developed by Goldberg [9] . This assay relies upon HA binding exogenous aggrecan, capture of unbound aggrecan on an HA coated plate and detection with the 5D4 MAb. HA (Sigma H1876, grade III) derived from human umbilical cord was stored at -20~ as a I mg/ml stock in water and diluted to 100 gg/ml concentration in standard coating buffer just before plate coating. Immulon 4 plates were coated with 100pl of diluted HA per well and incubated overnight at 4~
All subsequent dilutions and plate washes were performed in Tris IB. A special grade HA (Seikagaku 400724-1), also derived from human umbilical cord, was used as the standard competitor in these assays and maintained as a 1 mg/ml stock in water. Known concentrations of special grade HA competitor or SF samples were prepared in Tris IB. Sixty microliters of standard or sample were incubated with 60 ~1 BNC (ABC) core (final 0.25 pg/ml) overnight at 4~ Plates were blocked 90min at 37~ with 1% bovine serum albumin, then washed four times, followed by addition of 100 pl of the special grade HA/standard core protein mixture or 100 pl of the SF dilution/ standard core protein mixture, and incubated 1 h at 4~
Plates were washed, incubated with antibody 5D4, followed by secondary antibody and substrate as for the 5D4 ELISA.
STATISTICAL ANALYSIS
Demographic data were tabulated as means for continuous variables and as counts and percents for dichotomous variables. The Spearman correlation analysis was performed to compare chondral damage scores with individual cartilage marker levels. The Wilcoxon-Mann-Whitney two-sample test was used to compare the chondral damage scores for the dichotomous variables (presence or absence of ACL tear, meniscal injury or abnormal synovium), and to compare cartilage marker concentrations when chondral damage scores were dichotomized into patients with chondral damage (SFA > 0) and those without damage (SFA=0). Multivariable linear and logistic regression analyses were performed to evaluate for a correlation between cartilage marker concentrations and chondral damage scores. P-values less than or equal to 0.05 (two-sided) were considered significant. We used the SAS statistical package to perform all analyses [16] .
obtained from trauma-affected joints with no chondral damage (SFA=0) were compared with those that had chondral damage (SFA > 0), a significant decrease in the lesioned group for 3B3(-) epitope (P=0.008), and GAG (P=0.05) was observed (Table II) . In addition, when the statistical analysis was performed excluding the two individuals with previous remote knee trauma, results were unchanged.
COMPARISON OF ARTHROSCOPIC DATA TO CHONDRAL DAMAGE SCORE
To determine whether a particular internal derangement correlated with chondral damage, we performed a multivariate logistic regression analysis upon SFA score and lesion type. The finding of any meniscal pathology (N=13) was associated with an increased chondral damage score (P = 0.02) (Table III) . ACL tear (N= 16), either alone (N= 7) or in combination with meniscal injury (N=9), showed no independent correlation with chondral damage. The coexistence of abnormal synovium (N=13) showed no significant correlation with chondral damage.
Results
CORRELATION BETWEEN MARKERS AND CHONDRAL
DAMAGE
Eight participants had a chondral damage score of 0 indicating normal articular cartilage by direct visualization. The remaining 12 participants with chondral damage had a mean chondral damage score of 9.3 (range 0.7-30.6). Spearman correlation analysis showed a highly significant decrease in SF levels of 3B3(-) epitope (r~ =-0.62, P=0.004) with increased chondral damage score [ Fig. l(b) ]. A significant negative association was also found between GAG (rs =-0.49, P= 0.03) and increasing chondral damage score [ Fig. l(d) ]. No significant correlation was found between chondral damage score and levels of 3B3(+), KS and HA [ Fig. l(a) , (c) and (e)], SF volume, patient age, or time interval from injury. Nor was there a significant correlation of the concentration of any marker to time interval from injury, patient age, or SF volume. There was no significant effect of the presence of abnormal synovium on marker levels. Statistics were also performed using parametric techniques yielding the same results.
The group with SFA scores of 0 can be viewed as an internal control group. When the concerttrations of 3B3(-), 3B3(+), KS, HA, and GAG
PREDICTION OF CHONDRAL DAMAGE
Meniscat pathology correlated directly, while 3B3(-) epitope levels and GAG levels correlated inversely, with chondral damage scores (P _< 0.05). In the multivariable rank-transformed linear regression model, controlling for meniscal pathology, the relationship between 3B3(-) epitope levels and chondral damage score was still significant (P=0.01), with an odds ratio of 0.4, and 95% confidence interval of 0.002--0.636. However for GAG, results were no longer significant after controlling for meniscal pathology (P = 0.38).
Discussion
Previous studies have examined proteoglycan fragments in body fluids following injury, comparing levels to different methods of quantifying articular damage [17] [18] [19] [20] . Though arthroscopy has been considered the 'gold standard' for assessing articular cartilage [21, 22] , only recently has there been a validated system of quantification [13] . This system, developed by the SFA, yields a score that takes into account depth, size, and location of articular cartilage lesions in each compartment of the knee, and has demonstrated excellent intraobserver reliability. The scoring system as used in this study, with a single observer carrying out all the measurements, was sensitive enough to show a Intuitively, an increase in SF cartilage markers might be expected with increased chondral damage. However, the converse was observed by us and others [6, 8, [23] [24] [25] . We found that SF 3B3(-) epitope levels and GAG levels were inversely correlated to extent of articular cartilage damage.
Inverse correlations of SF markers and disease severity include, (1) proteoglycan and radio~ graphic severity in rheumatoid arthritis (RA) [23] , (2) KS and radiographic severity of OA [24] , (3) KS and acute knee injury compared with contralateral uninjured joint [8] , and (4) KS and GAG levels in OA and RA compared with normal controls [6] . Similar findings have also been seen with proteoglycan fragments, where SF levels were influenced by the mass of cartilage matrix remaining in the joint [26] . Our data demonstrate a change occurring in cartilage metabolism within the first 4 months of symptomatic knee injury.
Marker levels appear to reflect the volume of remaining normal cartilage or the metabolic state of the cartilage such that lower turnover occurs with increasingly severe lesions. Mean SF 3B3(-) epitope concentrations were approximately twofold higher in injured joints without chondral damage (SFA=0) compared with joints with chondral damage (SFA > 0). Although SF 3B3(-) epitope levels in normal human joints have not been reported previously to our knowledge, we are able to detect very small quantities of 3B3(-) epitope by ELISA in undiluted SF from normal mature canine joints (unpublished data). Levels of 3B3(-) from normal canine joints are 13-fold lower than the lowest 3B3(-) levels in effusive acute knee injury detected in the cohort with chondral damage. Thus, 3B3(-) levels in acute effusive knee injury appear to be elevated above normal and decline in conjunction with increasing chondral damage. Early decline of 3B3(-) following acute knee injury, and correlation of 3B3(-) levels with chondral pathology in our patients, suggest the potential of 3B3(-) to serve as a marker of cartilage lesion severity in this population. In our study, meniscal pathology was independently associated with articular cartilage damage independent of markers. We did not find an association between SF 3B3(+), KS or HA marker levels and extent of articular cartilage damage. This may be due, in part, to a small sample size. Although serum HA has demonstrated utility as a predictor of disease progression in humans with OA of the knee [27] , no correlation between SF HA and cartilage damage has been discerned in equine studies [28] . Synovium was defined as abnormal if hyperemia, thickening, or villous proliferation was seen at arthroscopy. We did not find a significant effect of these abnormalities on SF marker levels, although SF marker clearance is enhanced by calcium pyrophosphate dihydrate-induced synovitis [29] . It is possible that the inflammatory reaction in acute knee injury is too low initially to increase the clearance of proteoglycan fragments.
The use of body fluid markers for predicting articular cartilage damage is an optimistic goal with an ever increasing potential for realization as our understanding of cartilage biochemistry in health and disease is refined. A diagnostic algorithm may be possible in the future utilizing both biochemical markers and sensitive imaging techniques to identify patients for early intervention, prior to radiographically demonstrable cartilage damage. We were interested to find that the inverse correlation between lesion severity and SF markers was independent of time interval from injury within the 4 month interval from injury evaluated in this study. This results lends credence to the future possibility of predicting chondral damage by serial measurements of SF marker levels in a select population with acute knee injury. Continued diagnostic studies with larger numbers of subjects are needed before such a possibility can come to fruition and clinical use. 
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